372 filings
Page 3 of 19
6-K
fl7yt
23 Oct 23
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
4:16pm
6-K
w7h06qs7z3dqbrb4kva
16 Oct 23
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
6:14am
6-K
qkyxexz8
16 Oct 23
Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
6:03am
6-K
zkb5sdx1 jx
11 Sep 23
Current report (foreign)
4:03pm
6-K
xpk03 fstz5s9j0l
30 Aug 23
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
4:12pm
6-K
lgb8q4
14 Aug 23
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
8:34am
6-K
46bzr637202qcmy n5u2
7 Aug 23
Current report (foreign)
8:02am
6-K
jei9w
7 Aug 23
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
6:06am
6-K
11x6jayl
31 Jul 23
BioNTech Completes Acquisition of InstaDeep
8:12am
6-K
wxkmxaypcsom9ghqo0dw
29 Jun 23
Current report (foreign)
7:09am
6-K
p3879pk8fyig2
26 Jun 23
Current report (foreign)
5:26pm
6-K
qoki3n5hmpl 8ik7g
23 Jun 23
Current report (foreign)
4:41pm
6-K
obop0z lrkjq0y6hyu
2 Jun 23
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
8:51am
6-K
7zixqto9bd
2 Jun 23
Current report (foreign)
8:48am
6-K
ohv1md qdxae7s3
26 May 23
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission
7:43am
6-K
g9olbey pcc8un4rp
25 May 23
Changes in the Supervisory Board of BioNTech SE and Voting Results from the Annual General Meeting 2023
4:06pm
6-K
df5s6el60 fjskjmtn
8 May 23
Current report (foreign)
9:22am
6-K
ybh7r0ujqkdvj
8 May 23
Current report (foreign)
6:56am
6-K
0ze rmc0pmgamc3
8 May 23
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
6:53am
6-K
ydwdhnhe834 9ubyil
13 Apr 23
Invitation to the Annual General Meeting 2023
4:25pm